Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

282 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Management of Virologic Failure and HIV Drug Resistance.
McCluskey SM, Siedner MJ, Marconi VC. McCluskey SM, et al. Among authors: marconi vc. Infect Dis Clin North Am. 2019 Sep;33(3):707-742. doi: 10.1016/j.idc.2019.05.004. Epub 2019 Jun 27. Infect Dis Clin North Am. 2019. PMID: 31255384 Free PMC article. Review.
Prevalence of HIV-1 drug resistance after failure of a first highly active antiretroviral therapy regimen in KwaZulu Natal, South Africa.
Marconi VC, Sunpath H, Lu Z, Gordon M, Koranteng-Apeagyei K, Hampton J, Carpenter S, Giddy J, Ross D, Holst H, Losina E, Walker BD, Kuritzkes DR; South Africa Resistance Cohort Study Team. Marconi VC, et al. Clin Infect Dis. 2008 May 15;46(10):1589-97. doi: 10.1086/587109. Clin Infect Dis. 2008. PMID: 18419495 Free PMC article.
HIV treatment adherence, drug resistance, virologic failure: evolving concepts.
Nachega JB, Marconi VC, van Zyl GU, Gardner EM, Preiser W, Hong SY, Mills EJ, Gross R. Nachega JB, et al. Among authors: marconi vc. Infect Disord Drug Targets. 2011 Apr;11(2):167-74. doi: 10.2174/187152611795589663. Infect Disord Drug Targets. 2011. PMID: 21406048 Free PMC article. Review.
Cumulative viral load and virologic decay patterns after antiretroviral therapy in HIV-infected subjects influence CD4 recovery and AIDS.
Marconi VC, Grandits G, Okulicz JF, Wortmann G, Ganesan A, Crum-Cianflone N, Polis M, Landrum M, Dolan MJ, Ahuja SK, Agan B, Kulkarni H; Infectious Disease Clinical Research Program (IDCRP) HIV Working Group. Marconi VC, et al. PLoS One. 2011;6(5):e17956. doi: 10.1371/journal.pone.0017956. Epub 2011 May 20. PLoS One. 2011. PMID: 21625477 Free PMC article.
Early warning indicators for first-line virologic failure independent of adherence measures in a South African urban clinic.
Marconi VC, Wu B, Hampton J, Ordóñez CE, Johnson BA, Singh D, John S, Gordon M, Hare A, Murphy R, Nachega J, Kuritzkes DR, del Rio C, Sunpath H; South Africa Resistance Cohort Study Team Group Authors. Marconi VC, et al. AIDS Patient Care STDS. 2013 Dec;27(12):657-68. doi: 10.1089/apc.2013.0263. AIDS Patient Care STDS. 2013. PMID: 24320011 Free PMC article.
Lower prevalence of drug resistance mutations at first-line virological failure to first-line therapy with atripla vs. tenofovir + emtricitabine/lamivudine + efavirenz administered on a multiple tablet therapy.
Blanco JL, Montaner JS, Marconi VC, Santoro MM, Campos-Loza AE, Shafer RW, Miller MD, Paredes R, Harrigan R, Nguyen ML, Perno CF, Gonzalez-Hernandez LA, Gatell JM. Blanco JL, et al. Among authors: marconi vc. AIDS. 2014 Nov 13;28(17):2531-9. doi: 10.1097/QAD.0000000000000424. AIDS. 2014. PMID: 25574957
282 results